PASITHEA THERAPEUTICS CORP. Accumulated Other Comprehensive Income
PASITHEA THERAPEUTICS CORP. (KTTA) had Accumulated Other Comprehensive Income of $9.57 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $9.57K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $46.90K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $18.77K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $18.30K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | $9.57K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $46.90K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $18.77K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $18.30K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $5.63K 10-Q · filed 2025-08-14 |
| 2024-12-31 | -$7.17K 10-K · filed 2026-03-30 |
| 2024-09-30 | -$35.32K 10-Q · filed 2024-11-13 |
| 2024-06-30 | -$8.18K 10-Q · filed 2024-08-13 |
| 2024-03-31 | -$5.27K 10-Q · filed 2024-05-14 |
| 2023-12-31 | -$4.65K 10-K · filed 2025-03-24 |
| 2023-09-30 | -$7.72K 10-Q · filed 2023-11-13 |
| 2023-06-30 | -$3.46K 10-Q · filed 2023-08-11 |
| 2023-03-31 | -$3.14K 10-Q · filed 2023-05-12 |
| 2022-12-31 | -$661.00 10-K · filed 2024-03-29 |
| 2022-09-30 | -$146.57K 10-Q · filed 2022-11-14 |
| 2022-06-30 | -$64.06K 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$15.07K 10-Q · filed 2022-05-16 |
| 2021-12-31 | -$10.56K 10-K · filed 2023-03-30 |
| 2021-09-30 | -$3.76K 10-Q · filed 2021-11-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |